BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10748265)

  • 1. Functional characterization of bradykinin analogues on recombinant human bradykinin B(1) and B(2) receptors.
    Simpson PB; Woollacott AJ; Hill RG; Seabrook GR
    Eur J Pharmacol; 2000 Mar; 392(1-2):1-9. PubMed ID: 10748265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.
    Robert C; Pruneau D; Paquet JL
    Br J Pharmacol; 2002 Jan; 135(2):462-8. PubMed ID: 11815382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of bradykinin receptors in a human osteoblastic cell line.
    Brechter AB; Lerner UH
    Regul Pept; 2002 Jan; 103(1):39-51. PubMed ID: 11738247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.
    Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A
    Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
    Meini S; Lecci A; Maggi CA
    Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.
    Lin KS; Amouroux G; Pan J; Zhang Z; Jenni S; Lau J; Liu Z; Hundal-Jabal N; Colpo N; Bénard F
    J Nucl Med; 2015 Apr; 56(4):622-7. PubMed ID: 25745086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
    MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
    Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional studies of bradykinin receptors in Chinese hamster ovary cells stably expressing the human B2 bradykinin receptor.
    Zhang SP; Wang HY; Lovenberg TW; Codd EE
    Int Immunopharmacol; 2001 May; 1(5):955-65. PubMed ID: 11379050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-competitive pharmacological antagonism at the rabbit B(1) receptor.
    Larrivée JF; Gera L; Houle S; Bouthillier J; Bachvarov DR; Stewart JM; Marceau F
    Br J Pharmacol; 2000 Nov; 131(5):885-92. PubMed ID: 11053207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety.
    Amblard M; Daffix I; Bedos P; Bergé G; Pruneau D; Paquet JL; Luccarini JM; Bélichard P; Dodey P; Martinez J
    J Med Chem; 1999 Oct; 42(20):4185-92. PubMed ID: 10514288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of bradykinin B1 receptors in rat aortic smooth muscle cells.
    Schaeffer P; Laplace MC; Savi P; Prabonnaud V; Salel V; Herbert JM
    Biochem Pharmacol; 2001 Feb; 61(3):291-8. PubMed ID: 11172733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of bradykinin B1 and B2 receptors using rat isolated vas deferens.
    Scott P; Razzaque Z; Longmore J
    Eur J Pharmacol; 2003 Jan; 458(3):319-25. PubMed ID: 12504789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.
    Field JL; Butt SK; Morton IK; Hall JM
    Br J Pharmacol; 1994 Oct; 113(2):607-13. PubMed ID: 7834214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of bradykinin receptors in canine cultured corneal epithelial cells: pharmacological and functional studies.
    Huang SC; Hsiao LD; Chien CS; Wang CC; Chiu CT; Tsai RJ; Yang CM
    J Biomed Sci; 2002; 9(3):213-22. PubMed ID: 12065896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two B1 and B2 bradykinin receptor antagonists fail to inhibit the Ca2+ response elicited by bradykinin in human skin fibroblasts.
    Cassano G; Susca F; Lippe C; Guanti G
    Gen Pharmacol; 1999 Feb; 32(2):239-44. PubMed ID: 10188626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
    Butt SK; Dawson LG; Hall JM
    Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent, long-acting bradykinin antagonists for a wide range of applications.
    Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
    Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists.
    Wiernas TK; Griffin BW; Sharif NA
    Br J Pharmacol; 1997 Jun; 121(4):649-56. PubMed ID: 9208130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.